These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22121045)

  • 1. The structuring of GMO release and evaluation in EU law.
    von Kries C; Winter G
    Biotechnol J; 2012 Apr; 7(4):569-81. PubMed ID: 22121045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EU regulatory framework on genetically modified organisms (GMOs).
    Bruetschy C
    Transgenic Res; 2019 Aug; 28(Suppl 2):169-174. PubMed ID: 31321701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Options to Reform the European Union Legislation on GMOs: Risk Governance.
    Eriksson D; Custers R; Edvardsson Björnberg K; Hansson SO; Purnhagen K; Qaim M; Romeis J; Schiemann J; Schleissing S; Tosun J; Visser RGF
    Trends Biotechnol; 2020 Apr; 38(4):349-351. PubMed ID: 32171418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public health issues related with the consumption of food obtained from genetically modified organisms.
    Paparini A; Romano-Spica V
    Biotechnol Annu Rev; 2004; 10():85-122. PubMed ID: 15504704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.
    Beattie S;
    Hum Gene Ther; 2021 Oct; 32(19-20):997-1003. PubMed ID: 33843251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ethics of biotechnology.
    Lenoir N
    J Biolaw Bus; 2001; 4(2):6-10. PubMed ID: 12530386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GM Risk Assessment.
    Sparrow PA
    Methods Mol Biol; 2009; 478():315-30. PubMed ID: 19009454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically modified organisms: do the benefits outweigh the risks?
    Hug K
    Medicina (Kaunas); 2008; 44(2):87-99. PubMed ID: 18344661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Certain new plant breeding techniques and their marketability in the context of EU GMO legislation - recent developments.
    Zimny T; Sowa S; Tyczewska A; Twardowski T
    N Biotechnol; 2019 Jul; 51():49-56. PubMed ID: 30779963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JRC GMO-Amplicons: a collection of nucleic acid sequences related to genetically modified organisms.
    Petrillo M; Angers-Loustau A; Henriksson P; Bonfini L; Patak A; Kreysa J
    Database (Oxford); 2015; 2015():. PubMed ID: 26424080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Italy employs further GMO delay tactics.
    Meldolesi A
    Nat Biotechnol; 2003 Apr; 21(4):346. PubMed ID: 12665808
    [No Abstract]   [Full Text] [Related]  

  • 12. A tiered system for assessing the risk of genetically modified plants to non-target organisms.
    Garcia-Alonso M; Jacobs E; Raybould A; Nickson TE; Sowig P; Willekens H; Van der Kouwe P; Layton R; Amijee F; Fuentes AM; Tencalla F
    Environ Biosafety Res; 2006; 5(2):57-65. PubMed ID: 17328852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Governing GMOs in the USA: science, law and public health.
    Yang YT; Chen B
    J Sci Food Agric; 2016 Apr; 96(6):1851-5. PubMed ID: 26536836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Options to Reform the European Union Legislation on GMOs: Post-authorization and Beyond.
    Eriksson D; Custers R; Edvardsson Björnberg K; Hansson SO; Purnhagen K; Qaim M; Romeis J; Schiemann J; Schleissing S; Tosun J; Visser RGF
    Trends Biotechnol; 2020 May; 38(5):465-467. PubMed ID: 32302577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biotechnology, especially genetic modification, and legislation].
    de Sitter H; Peters PW
    Tijdschr Diergeneeskd; 2002 May; 127(10):322-30. PubMed ID: 12056264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EU biotech crop regulations and environmental risk: a case of the emperor's new clothes?
    Morris SH
    Trends Biotechnol; 2007 Jan; 25(1):2-6. PubMed ID: 17113665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current state of GMO governance: are we ready for GM animals?
    Vàzquez-Salat N; Salter B; Smets G; Houdebine LM
    Biotechnol Adv; 2012; 30(6):1336-43. PubMed ID: 22361646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Political will to lift the GMO moratorium emerging in Europe.
    Meldolesi A
    Nat Biotechnol; 2002 Aug; 20(8):758-9. PubMed ID: 12147986
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of genetically modified organisms (GMOs) in the European Union: principles of risk assessment.
    Anadón A; Roda L; Martínez-Larrañaga MR
    Vet Hum Toxicol; 2004 Dec; 46(6):340-1. PubMed ID: 15587259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bioeconomy in Poland within the context of the European Union.
    Woźniak E; Twardowski T
    N Biotechnol; 2018 Jan; 40(Pt A):96-102. PubMed ID: 28647548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.